Author Archives

Sonia CanzaterSonia Canzater
sc1574@georgetown.edu

Louisiana Proposes that the Federal Government Bypass Patent Restrictions to Acquire Cheaper Hepatitis C Drugs

By | Leave a Comment






Anyone who follows U.S. public health issues – or who reads my blog posts – knows that the cost of the drugs needed to treat Hepatitis C infections is very high. The cost of these drugs is of particular concern to state health authorities who are charged with providing health care for Medicaid recipients and […]

Read More

Posted in FDA, National Healthcare, Uncategorized; Tagged: .


COLLATERAL DAMAGE: REPEALING OBAMACARE WOULD ELIMINATE FUNDING FOR CRITICAL CDC PREVENTION PROGRAMS

By | Leave a Comment






There are many reasons for concern regarding the repercussions of a repeal of the Affordable Care Act, also known as Obamacare. Much of the focus as of late has been on the effect repeal would have on Medicaid recipients and how the cost of health insurance would change under a new plan. However, there are […]

Read More

Posted in Health reform, National Healthcare, Uncategorized; Tagged: , , , , .


Face the Facts: The benefit of continued support of stem cell research transcends partisan politics.

By | Leave a Comment






Stem cell research is a volatile scientific topic in the US, with supporters who are usually divided along political lines. Conservatives tend to view stem cell research – and particularly embryonic stem cell research – with disfavor. Thus, the new administration poses a threat to the continued support of research and innovation in this field, […]

Read More

Posted in Health reform, National Healthcare; Tagged: .


Obama signs $6.3 billion Cures Act – But Does it Do More Harm than Good?

By | Leave a Comment






On December 13th, President Obama signed the 21st Century Cures Act into law. This law provides $6.3 billion for cancer cure research, and to address the growing opioid drug abuse epidemic. The Act also allows for a more streamlined approval process for the FDA to bring new drugs and medical devices to the market. While […]

Read More

Posted in FDA, Health reform, Uncategorized; Tagged: , .


Now What?? The Potential Effects of a Trump Administration and Republican-Controlled Congress on Hepatitis C care

By | Leave a Comment






The 2016 presidential election ended in a result that few who are passionate about public health, human rights, and race, gender and sexual orientation equality could have ever wanted. However, as we face the reality of this reality, we who work to improve health outcomes must steel our resolve and continue to address the critical […]

Read More

Posted in Health reform, National Healthcare; Tagged: , .


Archives

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.